by The global Laparoscopic Gynecological Procedures market size is expected to be worth around US$ 46.13 billion by 2030, according to a new report by Vision Research Reports.
Laparoscopic Gynecological Procedures Market (By Procedure: Laparoscopic Hysterectomy, Laparoscopic Myomectomy, Laparoscopic Colpopexy, Laparoscopic Endometrial Excision, Laparoscopic Adnexal, Laparoscopic Diagnostic Procedures; By End-use: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs)) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38308
| Report Coverage | Details |
| Market Size | US$ 46.13 billion by 2030 |
| Growth Rate | CAGR of 10.7% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Procedure, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Medtronic; Stryker Corp.; Karl Storz SE & CO. Kg; Johnson and Johnson; Olympus Corp.; CONMED Corp.; B. Braun Melsungen AG; The Cooper Companies, Inc.; Richard Wolf GmbH; Microline Surgical; Welfare Medical Ltd.; Intuitive Surgical; Shenzen Mindray Bio Medical Electronics Co., Ltd. |
Report Highlights
the laparoscopic hysterectomy segment dominated the market accounting for the largest revenue share of 58.2%. On the basis of procedures, the market has been segmented into laparoscopic hysterectomy, laparoscopic myomectomy, laparoscopic colpopexy (sacrocolpopexy, sacrocervicopexy, etc.), laparoscopic endometrial excision, laparoscopic adnexal (oophorectomy, salpingooophorectomy, etc.), laparoscopic diagnostic procedures (requiring chromopertubation).
Laparoscopic hysterectomy is one of the widely used minimally invasive procedures for removing the uterus. This procedure has several advantages, such as the low risk of blood loss & infection and reduced hospital stays. Moreover, the risks of getting complications post-surgery are comparatively low. In addition, this procedure is inexpensive compared to a robotic hysterectomy. Thus, the aforementioned advantages drive its adoption, in turn, boosting the segment growth.
The hospitals segment held the largest revenue share of 57% in 2020. Hospitals offer superior care to patients and provide reimbursements for certain procedures, which are further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. These devices are not only simplifying treatment procedures but also providing better, faster, and accurate results.
Hospitals also witness a significantly high inflow of patients for laparoscopic procedures as compared to other healthcare settings, owing to ease of handling any emergencies that may arise during surgical procedures and availability of a broad range of treatment options. Thus, the aforementioned factors are expected to drive the growth of the hospitals segment.
On the basis of end use, the market has been segmented into hospitals, clinics, Ambulatory Surgery Centers (ASCs), and others. The growth of the hospitals segment can mainly be attributed to an increase in the number of patients suffering from various chronic ailments and consequent rise in surgical procedures.
The ASCs segment is expected to grow at the fastest CAGR over the forecast period. High preference for outpatient surgeries, increase in the adoption of minimally invasive surgeries, and cost-effectiveness of ASC-based laparoscopic procedures are key factors responsible for the lucrative growth of this segment. Lower postsurgical complications in minimally invasive laparoscopic surgery are expected to increase the demand for ASCs as they offer several advantages to patients, including shorter procedure time and same-day discharge.
North America dominated the global market accounting for the share revenue share of 40.72% in 2020 owing to the presence of well-established healthcare infrastructure, availability of skilled surgeons, and launch of technologically advanced products by the key market players. Growing awareness about the benefits of minimally invasive surgeries and laparoscopic procedures will drive the market growth over the forecast years. In addition, increasing healthcare expenditure in the U.S. may also favor the entry of both new and old players.
Key Players
- Medtronic
- Stryker Corp.
- Karl Storz SE & CO. Kg
- Johnson and Johnson
- Olympus Corp.
- CONMED Corp.
- B. Braun Melsungen AG
- The Cooper Companies, Inc.
- Richard Wolf GmbH
- Microline Surgical
- Welfare Medical Ltd.
- Intuitive Surgical
- Shenzen Mindray Bio Medical Electronics Co., Ltd.
Market Segmentation
- Procedure Outlook
- Laparoscopic Hysterectomy
- Laparoscopic Myomectomy
- Laparoscopic Colpopexy (Sacrocolpopexy, Sacrocervicopexy, etc.)
- Laparoscopic Endometrial Excision
- Laparoscopic Adnexal (Oophorectomy, SalpingoOophorectomy, etc.)
- Laparoscopic Diagnostic Procedures (Requiring Chromopertubation)
- End-use Outlook
- Hospitals
- Clinics
- Ambulatory Surgery Centers (ASCs)
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Qatar
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38308
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Laparoscopic Gynecological Procedures Market, By Procedure
7.1. Laparoscopic Gynecological Procedures Market, by Procedure, 2021-2030
7.1.1. Laparoscopic Hysterectomy
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Laparoscopic Myomectomy
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Laparoscopic Colpopexy (Sacrocolpopexy, Sacrocervicopexy, etc.)
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Laparoscopic Endometrial Excision
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Laparoscopic Adnexal (Oophorectomy, SalpingoOophorectomy, etc.)
7.1.5.1. Market Revenue and Forecast (2016-2030)
7.1.6. Laparoscopic Diagnostic Procedures (Requiring Chromopertubation)
7.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Laparoscopic Gynecological Procedures Market, By End-use
8.1. Laparoscopic Gynecological Procedures Market, by End-use, 2021-2030
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Clinics
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Ambulatory Surgery Centers (ASCs)
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Laparoscopic Gynecological Procedures Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.1.2. Market Revenue and Forecast, by End-use (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.2.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 10. Company Profiles
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Stryker Corp.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Karl Storz SE & CO. Kg
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Johnson and Johnson
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Olympus Corp.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. CONMED Corp.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. B. Braun Melsungen AG
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. The Cooper Companies, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Richard Wolf GmbH
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Microline Surgical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Welfare Medical Ltd.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Intuitive Surgical
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Shenzen Mindray Bio Medical Electronics Co., Ltd.
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38308
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
